All In MedTech

Device Trial Radar · NCT02487134

Trial of Routine Abdominal Wall Closure Versus Reinforcement With TIGR Matrix Onlay

Last checked: Nov 19, 2026Latest source record: Aug 14, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruitingPivotal-lookingRandomized with 200 participants. This is a heuristic, not a regulatory label.

Status

Not yet recruiting

Enrollment

200

Planned (sponsor's estimate)

Start

Jan 1, 2026

Primary completion

Jun 30, 2026

Study completion Jun 30, 2027

Sponsor

Lead sponsor
Karolinska InstitutetAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Jul 1, 2015

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Single group
Masking
Double (participant, outcomes assessor)
Primary purpose
Prevention
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Patients with at least two risk factors for incisional hernia undergoing abdominal surgery are eligible for inclusion. After accepting informed consent, patients are randomized into either closing the abdominal wall in a regular way with fascial sutures, or closing with fascial sutures together with placing a TIGR mesh as described. All patients are then monitored for signs of infection, wound rupture, incisional hernias, subcutaneous seroma as well as postoperative symptoms. All patients will be followed for at least 5 years. One year postoperatively, a computer scan is performed to detect asymptomatic incisional hernias.

Conditions

  • Open Wound of Abdominal Wall With Complication

Interventions

  • TIGR MatrixDevice

    Reinforcement of the suture line with resorbable mesh

  • ControlDevice

    Closure of the abdomen with conventional technique

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of patients with incisional hernia one year after surgeryTime frame: One year

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Karolinska University Hospital, Center for Digestive Diseases

    Stockholm, Sweden

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.